Clover Corporation Ltd
ASX:CLV

Watchlist Manager
Clover Corporation Ltd Logo
Clover Corporation Ltd
ASX:CLV
Watchlist
Price: 0.485 AUD Market Closed
Market Cap: 81m AUD
Have any thoughts about
Clover Corporation Ltd?
Write Note

Clover Corporation Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clover Corporation Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Clover Corporation Ltd
ASX:CLV
Research & Development
-AU$3.4m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
-6%
Hazer Group Ltd
ASX:HZR
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Titomic Ltd
ASX:TTT
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
First Graphene Ltd
ASX:FGR
Research & Development
-AU$1.7m
CAGR 3-Years
12%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Leaf Resources Ltd
ASX:LER
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Advance ZincTek Ltd
ASX:ANO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Clover Corporation Ltd
Glance View

Market Cap
81m AUD
Industry
Chemicals

Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company is headquartered in Melbourne, Victoria and currently employs 53 full-time employees. The Company’s geographical segments include Australia/New Zealand, Asia, Europe and America. The firm is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. The company focuses on developing nutrients for use in foods or as nutritional supplements. The firm provides lipid-based ingredients for the food industry. The company focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The company uses tuna oil, which has docosahexaenoic acid (DHA) for brain, nerve and eye tissue development in babies and infants. The company has a technology license for the encapsulation of marine and algal oils. The firm has a manufacturing plant for tuna oils and related products in Altona, Victoria.

CLV Intrinsic Value
0.818 AUD
Undervaluation 41%
Intrinsic Value
Price

See Also

What is Clover Corporation Ltd's Research & Development?
Research & Development
-3.4m AUD

Based on the financial report for Jul 31, 2024, Clover Corporation Ltd's Research & Development amounts to -3.4m AUD.

What is Clover Corporation Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-6%

Over the last year, the Research & Development growth was -31%. The average annual Research & Development growth rates for Clover Corporation Ltd have been -23% over the past three years , -14% over the past five years , and -6% over the past ten years .

Back to Top